```json
{
"content": [
{
"type": "paragraph",
"content": "The Small Animal Stereotaxic Frames market enables precise neurosurgical and neurological research in preclinical studies, primarily for rodent models. This device is critical for drug development, behavioral studies, and neurodegenerative disease research. The Small Animal Stereotaxic Frames market size is projected to reach $245 million by 2026, driven by advancements in neuroimaging technologies and rising R&D investments in biopharmaceutical sectors. With a CAGR of 6.8% (2026–2033), the market forecast underscores robust industry expansion fueled by demand for high-precision tools in neuroscience research."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Manual Frames", "Computerized Systems", "Hybrid Models"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[120, 125, 130, 135, 140, 145, 150, 155, 160, 165, 170, 175, 180], // Manual Frames
[80, 85, 90, 95, 100, 105, 110, 115, 120, 125, 130, 135, 140], // Computerized Systems
[50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 105, 110] // Hybrid Models
]
}
},
{
"type": "paragraph",
"content": "Key forces shaping the Small Animal Stereotaxic Frames market include the integration of AI-driven imaging software to enhance procedural accuracy and the adoption of customizable modular frames for diverse research applications. Regulatory approvals for preclinical trials in neurodegenerative therapies also drive adoption. North America remains the largest market due to established research infrastructure, while Asia-Pacific is the fastest-growing region, spurred by low-cost R&D facilities in India and China. Competitive dynamics are intensifying as manufacturers prioritize innovation to meet evolving precision requirements in translational medicine."
}
]
}
```
